Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options

Fulton Joel; Harrod Alison; Van Nguyen; Periyasamy Manikandan; Garcia Laura Ramos; Lai Chun-Fui; de Giorgio Alex; Metodieva Gergana

首页> 外文期刊>Breast cancer research and treatment. >Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options

【24h】

Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options

机译：CRISPR-Cas9介导的ESR1突变敲除突变在转移性乳腺癌中的应用可进行功能分析和评估治疗方案

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Breast cancer research and treatment.》 |2016年第1期|共1页
作者
Fulton Joel; Harrod Alison; Van Nguyen; Periyasamy Manikandan; Garcia Laura Ramos; Lai Chun-Fui; de Giorgio Alex; Metodieva Gergana;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options [J] . Fulton Joel, Harrod Alison, Van Nguyen, Breast cancer research and treatment. . 2016,第1期

机译：CRISPR-Cas9介导的ESR1突变敲除突变在转移性乳腺癌中的应用可进行功能分析和评估治疗方案
2. The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer [J] . Sasha M. Pejerrey, Derek Dustin, Jin-Ah Kim, Hormones & cancer . 2018,第4期

机译：ESR1突变对转移乳腺癌治疗的影响
3. Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis [J] . Kai Zhang, Ruoxi Hong, Fei Xu, Cancer Management and Research . 2018,第4期

机译：转移乳腺癌患者循环ESR1突变的临床价值：META分析
4. A Single Tube Screening of Endocrine Therapy Resistance ESR1 Mutations in ER-Positive Breast Cancer [C] . Akihiro Tsuyada, Shunsuke Nakano, Toshimitsu Ichijo, International Molecular Medicine Tri-Conference. . 2016

机译：ER阳性乳腺癌内分泌治疗抗ESR1突变的单管筛选
5. Mechanisms of Action of Non-canonical ESR1 Ligand Domain Mutations Identified in Breast Cancer [D] . Gadiya, Mayur 2020

机译：乳腺癌中非规范性ESR1配体域突变的作用机制。
6. Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis [O] . Kai Zhang, Ruoxi Hong, Fei Xu, 2018

机译：循环ESR1突变在转移性乳腺癌患者中的临床价值：一项荟萃分析
7. ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients [O] . Angus, Lindsay, Beije, Nick, Jäger, A., 2017

机译：ESR1突变：转移性乳腺癌患者的指导治疗决策制定

Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options

著录项

相似文献

相关主题

期刊订阅